BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fu YX, Ji J, Shan F, Li J, Hu R. Human mesenchymal stem cell treatment of premature ovarian failure: new challenges and opportunities. Stem Cell Res Ther 2021;12:161. [PMID: 33658073 DOI: 10.1186/s13287-021-02212-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Fan W, Qi Y, Wang Y, Yan H, Li X, Zhang Y. Messenger roles of extracellular vesicles during fertilization of gametes, development and implantation: Recent advances. Front Cell Dev Biol 2022;10:1079387. [PMID: 36684431 DOI: 10.3389/fcell.2022.1079387] [Reference Citation Analysis]
2 Zafardoust S, Kazemnejad S, Darzi M, Fathi-kazerooni M, Saffarian Z, Khalili N, Edalatkhah H, Mirzadegan E, Khorasani S. Intraovarian Administration of Autologous Menstrual Blood Derived-Mesenchymal Stromal Cells in Women with Premature Ovarian Failure. Archives of Medical Research 2023. [DOI: 10.1016/j.arcmed.2022.12.015] [Reference Citation Analysis]
3 Umer A, Khan N, Greene DL, Habiba UE, Shamim S, Khayam AU. The Therapeutic Potential of Human Umbilical Cord Derived Mesenchymal Stem Cells for the Treatment of Premature Ovarian Failure. Stem Cell Rev and Rep 2022. [DOI: 10.1007/s12015-022-10493-y] [Reference Citation Analysis]
4 Ali I, Padhiar AA, Wang T, He L, Chen M, Wu S, Zhou Y, Zhou G. Stem Cell-Based Therapeutic Strategies for Premature Ovarian Insufficiency and Infertility: A Focus on Aging. Cells 2022;11. [PMID: 36496972 DOI: 10.3390/cells11233713] [Reference Citation Analysis]
5 Huang Y, Zhu M, Liu Z, Hu R, Li F, Song Y, Geng Y, Ma W, Song K, Zhang M. Bone marrow mesenchymal stem cells in premature ovarian failure: Mechanisms and prospects. Front Immunol 2022;13:997808. [PMID: 36389844 DOI: 10.3389/fimmu.2022.997808] [Reference Citation Analysis]
6 Garg K, Zilate S. Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Infertility Due to Premature Ovarian Failure. Cureus 2022. [DOI: 10.7759/cureus.30529] [Reference Citation Analysis]
7 Saeed Y, Liu X. Mesenchymal stem cells to treat female infertility; future perspective and challenges: A review. Int J Reprod Biomed 2022;20:709-22. [PMID: 36340664 DOI: 10.18502/ijrm.v20i9.12061] [Reference Citation Analysis]
8 Cen S, Qian X, Wu C, Xu X, Yang X. Efficacy and Clinical Significance of the Zuogui Pill on Premature Ovarian Failure via the GDF-9/Smad2 Pathway. Nutr Cancer 2022;:1-10. [PMID: 36194038 DOI: 10.1080/01635581.2022.2123531] [Reference Citation Analysis]
9 Huang QY, Chen SR, Zhao YX, Chen JM, Chen WH, Lin S, Shi QY. Melatonin enhances autologous adipose-derived stem cells to improve mouse ovarian function in relation to the SIRT6/NF-κB pathway. Stem Cell Res Ther 2022;13:399. [PMID: 35927704 DOI: 10.1186/s13287-022-03060-2] [Reference Citation Analysis]
10 Geng Z, Chen H, Zou G, Yuan L, Liu P, Li B, Zhang K, Jing F, Nie X, Liu T, Zhang B, Li Q. Human Amniotic Fluid Mesenchymal Stem Cell-Derived Exosomes Inhibit Apoptosis in Ovarian Granulosa Cell via miR-369-3p/YAF2/PDCD5/p53 Pathway. Oxidative Medicine and Cellular Longevity 2022;2022:1-18. [DOI: 10.1155/2022/3695848] [Reference Citation Analysis]
11 Qu Q, Liu L, Cui Y, Liu H, Yi J, Bing W, Liu C, Jiang D, Bi Y. miR-126-3p containing exosomes derived from human umbilical cord mesenchymal stem cells promote angiogenesis and attenuate ovarian granulosa cell apoptosis in a preclinical rat model of premature ovarian failure. Stem Cell Res Ther 2022;13:352. [PMID: 35883161 DOI: 10.1186/s13287-022-03056-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Li Y, Yan M, Chen Q, Xie Y, Li C, Han F. Current Research on Complementary and Alternative Medicine in the Treatment of Premature Ovarian Failure: An Update Review. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-18. [DOI: 10.1155/2022/2574438] [Reference Citation Analysis]
13 He F, Liu Y, Li T, Ma Q, Yongmei Z, He P, Xiong C. MicroRNA-146 attenuates lipopolysaccharide induced ovarian dysfunction by inhibiting the TLR4/NF- κB signaling pathway. Bioengineered 2022;13:11611-23. [DOI: 10.1080/21655979.2022.2070584] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Wang J, Liu W, Yu D, Yang Z, Li S, Sun X. Research Progress on the Treatment of Premature Ovarian Failure Using Mesenchymal Stem Cells: A Literature Review. Front Cell Dev Biol 2021;9:749822. [PMID: 34966738 DOI: 10.3389/fcell.2021.749822] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
15 Jahanbani Y, Shafiee S, Davaran S, Roshangar L, Ahmadian E, Eftekhari A, Dolati S, Yousefi M. Stem cells technology as a platform for generating reproductive system organoids and treatment of infertility-related diseases. Cell Biol Int 2021. [PMID: 34918417 DOI: 10.1002/cbin.11747] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Chadaeva I, Ponomarenko P, Kozhemyakina R, Suslov V, Bogomolov A, Klimova N, Shikhevich S, Savinkova L, Oshchepkov D, Kolchanov NA, Markel A, Ponomarenko M. Domestication Explains Two-Thirds of Differential-Gene-Expression Variance between Domestic and Wild Animals; The Remaining One-Third Reflects Intraspecific and Interspecific Variation. Animals (Basel) 2021;11:2667. [PMID: 34573632 DOI: 10.3390/ani11092667] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
17 Pennarossa G, De Iorio T, Gandolfi F, Brevini TAL. Ovarian Decellularized Bioscaffolds Provide an Optimal Microenvironment for Cell Growth and Differentiation In Vitro. Cells 2021;10:2126. [PMID: 34440895 DOI: 10.3390/cells10082126] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]